Posted on 2/9/21
Rep. Brown: ‘Maryland Can’t Get Better Than A D’ On COVID-19 Vaccine Distribution
U.S. Rep. and former Lt. Gov. Anthony Brown (D-Md.) Monday slammed Gov. Larry Hogan’s administration’s stewardship of coronavirus vaccine distribution, saying the state has a “broken . . .
Posted on 2/9/21
TYME Closes $100M Registered Direct Offering of Common Stock
BEDMINSTER, N.J.--(BUSINESS WIRE)--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies, announced that today it closed its previously announced registered direct offering . . .
Posted on 2/9/21
Quanterix Closes Public Offering Including Exercise of Underwriters’ Option
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced the closing of its previously announced . . .
Posted on 2/9/21
Florida Governor Ron DeSantis Appoints Albizu University Doctoral Graduate Dr. Madiley Broz to Florida Board of Psychology
Albizu University master’s and doctoral graduate Dr. Madiley Broz of Miami was among four psychology professionals
Posted on 2/9/21
MD NOW Offers Antibody Testing for COVID-19
Testing can help detect effectiveness of vaccine and determine assumed current immunity MD NOW® Urgent Care, the largest urgent care provider in Florida, is offering COVID-19 . . .
Posted on 2/9/21
AyuVis’ Lead Drug Candidate – AVR-48 -- Granted Rare Pediatric Disease Drug Designation
AyuVis Research, Inc.’s proprietary small molecule drug AVR-48, which last month was granted Orphan Drug Designation (ODD) from the U.S. Food and Drug Administration (FDA), additionally . . .
Posted on 2/9/21
Maryland Confirms 903 New Coronavirus Cases, 23 Deaths
Maryland health officials on Monday reported 903 new coronavirus cases and 23 more deaths related to COVID-19.As of Monday morning, a total of 364,553 Marylanders have . . .
Posted on 2/9/21
Mayor Scott to Johnson & Johnson: Sell 300K Baltimore-manufactured COVID-19 Vaccine Doses to City
In response to the pandemic, we’ve seen collaboration between life sciences companies that are putting local facilities
Posted on 2/9/21
A Baltimore Lab Developed Technology for a Molecular Rapid COVID-19 Test
A new company is developing molecular technology for a rapid COVID-19 test that is designed to be just as effective
Posted on 2/8/21
Akebia Therapeutics to Report Fourth Quarter and Full-Year 2020 Financial Results
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced plans to release . . .
Posted on 2/8/21
Tonix Pharmaceuticals Holdings Corp. Prices $70M Common Stock
CHATHAM, N.J., Feb. 08, 2021 (GLOBE NEWSWIRE) -- TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP), a clinical-stage biopharmaceutical company, today announced it has entered into a securities . . .
Posted on 2/8/21
RespireRx Pharmaceuticals Announces 10 to 1 Reverse Stock Split
Glen Rock, N.J., Feb. 08, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) has been up listed from the OTC Pink Market and returns to . . .
Posted on 2/8/21
2021’s Healthiest & Unhealthiest Cities in America – WalletHub Study
With health care costs rising and the U.S. facing one of the worst health crises in decades with the COVID-19 pandemic, the personal-finance website WalletHub today . . .
Posted on 2/8/21
SmartBreast Acquires Molecular Breast Imaging Assets from GE Healthcare
SmartBreast Corporation, a privately held company focused on breast cancer screening and diagnosis, announced today that it has acquired the Discovery NM750b Molecular Breast Imaging (MBI) . . .
Posted on 2/8/21
Next-Gen Proteomics Company Nautilus Biotechnology to List on Nasdaq Through Merger with Arya Sciences Acquisition Corp III
SEATTLE & NEW YORK--(BUSINESS WIRE)--Nautilus Biotechnology, Inc., a company pioneering a single-molecule protein analysis platform for quantifying the human proteome, and Arya Sciences Acquisition Corp III . . .
Posted on 2/8/21
Gemini Therapeutics Debuts as Publicly Traded Precision Medicine Company Focused on Age-Related Macular Degeneration
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Gemini Therapeutics, a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular degeneration (AMD), today announced the completion of its . . .
Posted on 2/8/21
Paragon Data Labs Secures Angel Investment
NEW YORK--(BUSINESS WIRE)--Paragon Data Labs, the creators of Compliance Administration & Tracking (CAT), a cloud-based enterprise compliance platform, is pleased to announce its first round of . . .
Posted on 2/8/21
South African COVID-19 Variant Case Reported in Va., Governor Says
UPDATED 4 P.M. FEB. 5Gov. Ralph Northam said Friday the highly contagious South African variant of COVID-19 has shown up in a case in Virginia, identified . . .
Posted on 2/8/21
Should You Buy Lexicon Pharmaceuticals Stock?
Investing in biotech stocks is a risky endeavor, but sometimes you can eke out a return without facing as much potential trouble as usual. By identifying . . .
Posted on 2/8/21
Is Novavax Still a Buy After Doubling in Two Days?
Novavax (NASDAQ:NVAX) soared more than 2,000% in 2020 as investors bet on the future of its coronavirus vaccine candidate. Then it extended gains at a reasonable . . .
Posted on 2/8/21
When Will Johnson & Johnson's Coronavirus Vaccine Be Available?
Johnson & Johnson (NYSE:JNJ) released clinical trial results for its one-dose coronavirus vaccine last week, but it'll be a few weeks before the vaccine could be . . .
Posted on 2/8/21
2 Green Flags in Johnson & Johnson's Latest Earnings Report
What did we learn about the world's largest healthcare company when it kicked off the sector's earnings season? In this Motley Fool Live video recorded on . . .
Posted on 2/8/21
Johnson & Johnson's Vaccine Is Less Effective Than Rivals. Here's Why It Could Still Win Big
Johnson & Johnson (NYSE:JNJ) is about to cross the coronavirus vaccine race finish line. But cheers may not be as loud as they were for rivals . . .
Posted on 2/8/21
1 Green Flag and 1 Red Flag From Pfizer's Earnings
Despite co-developing the first COVID-19 vaccine to be authorized in the U.S. and undergoing a transformational spinoff, Pfizer's (NYSE:PFE) stock closed out 2020 almost exactly where . . .
Posted on 2/8/21
1 Big Problem in Johnson & Johnson's Latest Earnings Call
Johnson & Johnson (NYSE:JNJ) pleased investors with a fourth-quarter earnings call that was generally positive. Unfortunately, the coronavirus pandemic continues to pressure one of the company's . . .
